CHE、Lac、Lcr联合检测对重症SAP患者预后预测价值的研究

唐晓霞, 徐杰, 马宇杰, 等. CHE、Lac、Lcr联合检测对重症SAP患者预后预测价值的研究[J]. 临床急诊杂志, 2020, 21(3): 217-221. doi: 10.13201/j.issn.1009-5918.2020.03.008
引用本文: 唐晓霞, 徐杰, 马宇杰, 等. CHE、Lac、Lcr联合检测对重症SAP患者预后预测价值的研究[J]. 临床急诊杂志, 2020, 21(3): 217-221. doi: 10.13201/j.issn.1009-5918.2020.03.008
TANG Xiaoxia, XU Jie, MA Yujie, et al. Predictive value of combined detection of serum cholinesterase, lactate and lactate clearance rate on the prognosis of patients with severe stroke associated pneunomia[J]. J Clin Emerg, 2020, 21(3): 217-221. doi: 10.13201/j.issn.1009-5918.2020.03.008
Citation: TANG Xiaoxia, XU Jie, MA Yujie, et al. Predictive value of combined detection of serum cholinesterase, lactate and lactate clearance rate on the prognosis of patients with severe stroke associated pneunomia[J]. J Clin Emerg, 2020, 21(3): 217-221. doi: 10.13201/j.issn.1009-5918.2020.03.008

CHE、Lac、Lcr联合检测对重症SAP患者预后预测价值的研究

  • 基金项目:

    2018年度河北省医学科学研究重点课题计划(No:20181450)

详细信息
    通讯作者: 唐晓霞,E-mail:tangxiaoxia77@163.com
  • 中图分类号: R563.1

Predictive value of combined detection of serum cholinesterase, lactate and lactate clearance rate on the prognosis of patients with severe stroke associated pneunomia

More Information
  • 目的:探讨血清胆碱酯酶(CHE)、乳酸(Lac)、乳酸清除率(Lcr)及联合检测对重症卒中相关性肺炎(SAP)患者预后的预测价值。方法:选取2016-09-2018-08期间急诊重症监护室(EICU)收治的116例重症SAP患者为研究对象,根据28 d是否存活分为存活组(67例)和死亡组(49例)。检测两组患者血CHE、入院时及入院24 h血Lac值;计算乳酸清除率及急性生理与慢性健康评分Ⅱ(APACHEⅡ)。分析各指标及指标联合检测对重症SAP患者预后的预测价值。结果:多因素非条件Logistic回归分析结果显示,APACHEⅡ评分、血清CHE、24 h Lac及Lcr对判断重症SAP预后具有统计学意义(P<0.05),受试者工作特征曲线(ROC曲线)下面积分别为0.682、0.670、0.634及0.690。联合指标曲线下面积为0.818,灵敏度和特异度分别为0.796和0.731。结论:APACHEⅡ评分、血清CHE、24 h Lac及Lcr可用于判断重症SAP预后,联合检测可显著提高预测价值。
  • 加载中
  • [1]

    卒中相关性肺炎诊治中国专家共识组.卒中相关性肺炎诊治中国专家共识[J].中华内科杂志,2010,49(12):1075-1078.

    [2]

    温德良,李智博,温艺超,等.重症监护病房脑卒中相关性肺炎多重耐药菌感染的危险因素及病原学分析[J].实用医学杂志,2016,32(13):2178-2181.

    [3]

    莫新,唐皓,曾丽金,等.血清胆碱酯酶含量对重症肺炎患者病情和预后的评估价值[J].中华危重病急救医学,2016,28(1):38-43.

    [4]

    秦雪梅,赵琪林.慢性乙型肝炎患者病情严重程度与血清胆碱酯酶的相关性研究[J].医学临床研究,2017,34(8):1478-1480.

    [5]

    Yamamoto M,Saito H,Uejima C,et al.Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer[J].Anticancer Res,2019,39(2):1085-1090.

    [6]

    Vartolomei MD,D'Andrea D,Chade DC,et al.Role of serum cholinesterase In patients treated with salvage radical prostatectomy[J].Urol Oncol,2019,37(2):123-129.

    [7]

    俞冲,韩旭东,顾玉玲.48小时内血清降钙素原与动脉乳酸清除率对判断脓毒性休克患者预后的价值[J].中华实验和临床感染病杂志(电子版),2018,12(2):140-143.

    [8]

    方荣,王倩,欧阳洋,等.乳酸清除率与降钙素原及C反应蛋白和重症肺炎预后的相关性分析[J].临床急诊杂志,2018,19(7):463-467.

    [9]

    Choudhary R,Sitaraman S,Choudhary A.et al.Lactate clearance as the predictor of outcome in pediatric septic shock[J].J Emerg Trauma Shock,2017,10(2):55-59.

    [10]

    Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of American/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adult[J].Clin Infect Dis,2007,44(Suppl 2):S27-72.

    [11]

    Hilker R,Poetter C,Findeisen N,et al.Nosocominal pneumonia after acute stroke:implications for neurological intensive care medicine[J].Stroke,2003,34(4):975-981.

    [12]

    王娜,王丰容,刘芦姗.急诊病房脑卒中相关性肺炎的危险因素及预后分析[J].中国康复理论与实践,2017,23(8):932-936.

    [13]

    李海燕,戴缤,沈光莉,等.急性脑出血并发相关性肺炎的临床特点及危险因素分析[J].中华老年医学杂志,2017,36(3):274-277.

    [14]

    Eltringham SA,Kilner K,Gee M,et al.Impact of Dysphagia Assessment and Management on Risk of Stroke-Associated Pneumonia:A Systematic Review[J].Cerebrovasc Dis,2018,46(3-4):99-107.

    [15]

    Bruening T,Al-Khaled M.Stroke-Associated Pneumonia in Thrombolyzed Patients:Incidence and Outcome[J].J Stroke Cerebrovasc Dis,2015,24(8):1724-1729.

    [16]

    Ali AN,Howe J,Majid A,et al.The economic cost of stroke-associated pneumonia in a UK setting[J].Top Stroke Rehabil,2018,25(3):214-223.

    [17]

    Zapata-Arriaza E,Moniche F,Blanca PG,et al.External Validation of the ISAN,A2DS2,and AIS-APS Scores for Predicting Stroke-Associated Pneumonia[J].J Stroke Cerebrovasc Dis,2018,27(3):673-676.

    [18]

    Naqvi IH,Mahmood K,Ziaullaha S,et al.Better prognostic marker in ICU-APACHE Ⅱ,SOFA or SAP Ⅱ[J].Pak J Med Sci,2016,32(5):1146-1151.

    [19]

    Cheng JY.Mortality prediction in status epilepticus with the APACHE Ⅱ score[J].J Intensive Care Soc,2017,18(4):310-317.

    [20]

    张璐璐,陈亮,郑辉才,等.血清ChE在老年COPD合并呼吸衰竭患者预后判断中的价值[J].山东医药,2018,58(41):76-79.

    [21]

    周志菁,林芳祟,赵会必,等.血清胆碱酯酶与过氧化脂质对重度脓毒症患者生存状况的影响[J].中华医院感染学杂志,2019,29(1):40-43.

    [22]

    Kimura S,Soria F,D'Andrea D,et al.Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer[J].Clin Genitourin Cancer,2018,16(6):el123-el132.

    [23]

    Bahloul M,Baccouch N,Chtara K,et al.Value of Serum Cholinesterase Activity in the Diagnosis of Septic Shock Due to Bacterial Infections[J].J Intensive Care Med,2017,32(5):346-352.

  • 加载中
计量
  • 文章访问数:  96
  • PDF下载数:  57
  • 施引文献:  0
出版历程
收稿日期:  2019-05-23

目录